The shares of Ocugen Inc. (OCGN) are up 3.58% to $6.67 in early trading this morning. The Ocugen stock was down by -4.17% to $6.44
Shares of Ocugen, Inc. (OCGN) stock were down in the per market trading session today after recording the gain of 6.69% with an $11.96 per
Ocugen (OCGN) stock is a relatively new biotechnology company specializing in diverse and lucrative fields such as gene therapy and Covid 19 vaccines. In February,
Stock markets recovered strongly from the price dip at the end of January last week. In New York, the indices even managed to set new
Ocugen, Inc. (OCGN) was up another 60% in aftermarket trading on Friday after the company announced it had signed definitive agreements for the sale of
Futures for major US stock indices rose on Thursday in anticipation of labor market statistics and a new portion of corporate reporting, according to trading
Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-market trading. The company recently granted 180-day extension by Nasdaq to regain compliance with
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
Avinger Inc. (AVGR) stock plunged -7.38% to $0.4445 in the pre-market trading. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is a
On December 24, American stock indices closed in the green. The S&P 500 Index climbed 0.35% to 3690 points, the Dow Jones added 0.23%, the NASDAQ
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.